Zobrazeno 1 - 6
of 6
pro vyhledávání: '"MF Kergueris"'
Autor:
Michel Krempf, S. Ranganathan, J.Sérgio Marchini, C. Azoulay, MF Kergueris, N. Faisant, Hugues Piloquet, Martine Champ
Publikováno v:
Nutrition Research. 18:1135-1145
The purpose of this study was to evaluate the lipid and glucose response after an acute intake of raw resistant potato starch. Ten healthy volunteers (6 males and 4 females, aged 19–27 years old, a body mass index of 22.4±0.8 kg·m −2 ) particip
Publikováno v:
Europe PubMed Central
The pharmacokinetics of melphalan were studied in 20 patients with multiple myeloma, primary amyloidosis or lymphoma after IV dose of 140 mg/m2 infused over 30 minutes (two patients were treated with a higher dose).Six patients received melphalan alo
Publikováno v:
Reproduction Nutrition Development. 34:617-618
Autor:
Revol B; Grenoble Alpes University Hospital, Addictovigilance Dept, Grenoble, France; Grenoble Alpes University, HP2 Lab, Inserm U1300, Grenoble, France. Electronic address: brevol@chu-grenoble.fr., Willeman T; Grenoble Alpes University Hospital, Pharmacology Pharmacogenetics & Toxicology Lab, Grenoble, France; Grenoble Alpes University Hospital, Clinical Forensic Medicine Dept, Grenoble, France., Manceau M; Grenoble Alpes University Hospital, Clinical Research Centre, Inserm CIC1406, Grenoble, France., Dumestre-Toulet V; ToxGen Lab, Bordeaux, France., Gaulier JM; Lille University Hospital, Toxicology Dept, Lille, France., Eysseric-Guérin H; Grenoble Alpes University Hospital, Pharmacology Pharmacogenetics & Toxicology Lab, Grenoble, France; Grenoble Alpes University, Forensics Lab, Grenoble, France., Fouilhé Sam-Laï N; Grenoble Alpes University Hospital, Addictovigilance Dept, Grenoble, France.
Publikováno v:
Public health [Public Health] 2024 Nov; Vol. 236, pp. 381-385. Date of Electronic Publication: 2024 Sep 19.
Autor:
Revol B; Addictovigilance Department, Grenoble Alpes University Hospital, Grenoble, France.; HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France., Willeman T; Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, Grenoble, France.; Clinical Forensic Medicine Department, Grenoble Alpes University Hospital, Grenoble, France., Manceau M; Clinical Research Center, Inserm CIC1406, Grenoble Alpes University Hospital, Grenoble, France., Dumestre-Toulet V; ToxGen Laboratory, Bordeaux, France., Gaulier JM; Toxicology Unit, Lille University Hospital, Lille, France., Fouilhé Sam-Laï N; Addictovigilance Department, Grenoble Alpes University Hospital, Grenoble, France., Eysseric-Guérin H; Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, Grenoble, France.; Forensic Laboratory, Grenoble Alpes University, Grenoble, France.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Aug 01; Vol. 6 (8), pp. e2331398. Date of Electronic Publication: 2023 Aug 01.
Autor:
Djezzar S; Pharmacodependence Center, Hôpital Fernand Widal, Assistance Publique-Hôpitaux de Paris, Paris, France. samira.djezzar@lrb.aphp.fr, Questel F, Burin E, Dally S
Publikováno v:
International journal of legal medicine [Int J Legal Med] 2009 May; Vol. 123 (3), pp. 213-9. Date of Electronic Publication: 2008 Oct 17.